510(k) Report

510(k) · Cleared

Cleared

Amo Prestige Day Pack (Allergan, Inc.)

K962402510(k) TraditionalCleared Sep 19, 199690-day reviewClass II21 CFR 886.4670

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Allergan, Inc. · HQC Unit, Phacofragmentation

Cleared on Sep 19, 1996 after a 90-day review. The FDA summary names its predicate without a number.

Decided
Sep 19, 1996
Review
90 days
Class
Class II
Product code
HQC
Recalls
None
Predicates
0

The FDA summary names its predicate without a number.

FIG. 1 — Lineage of K962402Source: FDA 510(k) database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in HQC? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new HQC device

  1. #1 K261264 Stellaris Elite™ vision enhancement system…score 13.4 · 8 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (5)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—AMO® Prestige® Pack (Disposable, Sterile), OPO-40
Named without a submission number
—
*—AMO® One Bottle Reusable Tubing (Sterile)
Named without a submission number
—
*—AMO® One Bottle Disposable Tubing (Sterile)
Named without a submission number
—
*—AMO® Irrigation Administration Set (Sterile)
Named without a submission number
—
*—AMO® T-Fitting (Non-Sterile)
Named without a submission number
—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All HQC devices

HQC Unit, Phacofragmentation: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · HQC

3in 2025

2008: 42009: 52010: 32011: 52012: 52014: 42015: 32016: 12017: 32019: 42020: 42021: 12022: 42023: 12024: 52025: 32026 (partial year): 3
2007high 5 (2009) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · HQC

267in 2025

2008: 162 days median2009: 131 days median2010: 142 days median2011: 129 days median2012: 125 days median2014: 135 days median2015: 124 days median2017: 214 days median2019: 126 days median2020: 227 days median2022: 245 days median2024: 197 days median2025: 267 days median2026 (partial year): 115 days median
2007high 267 (2025) · low 124 (2015)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · HQC

1in 2025

2008: 12009: 12010: 222011: 42012: 12014: 12018: 22022: 52023: 12025: 1
2007high 22 (2010) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · HQC

1,799in 2025

2007: 3412008: 4442009: 5402010: 2,4312011: 1,8022012: 2,2772013: 2,7722014: 2,7402015: 3,3552016: 3,3742017: 2,7812018: 2,4162019: 2,2872020: 1,2172021: 1,6732022: 1,9072023: 1,7992024: 2,1202025: 1,799
2007high 3,374 (2016) · low 341 (2007)2025

MAUDE reports naming product code HQC, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—0341
200841621444
200951311540
20103142222,431
2011512941,802
2012512512,277
20130—02,772
2014413512,740
2015312403,355
20161—03,374
2017321402,781
20180—22,416
2019412602,287
2020422701,217
20211—01,673
2022424551,907
20231—11,799
2024519702,120
2025326711,799
202631150—

What is it indicated for?

The AMO® Prestige® Day Pack supports the irrigation fluid path for replenishing intraocular fluid removed during cataract extraction. The tubing pack also supports the aspiration fluid path for removing fluid and nuclear fragments during cataract surgery.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K962402: Amo Prestige Day Pack (Allergan, Inc.).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K962402

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Page last updated Nov 3, 2026